Sorry, you need to enable JavaScript to visit this website.

Pfizer supports the global healthcare community’s independent initiatives (e.g., research, quality improvement or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies.

Pfizer’s competitive grant program involves a publicly posted Request for Proposal (RFP) that provides detail regarding a specific area of interest and sets timelines for review and approval. Organizations are invited to submit an application addressing the specific gaps in research, practice or care as outlined in the specific RFP. The grant requester (and ultimately the grantee) is responsible for the design, implementation, sponsorship, and conduct of the independent initiative supported by the grant, including compliance with any regulatory requirements.

Sign-up to receive all GMG announcements, including Request for Proposal (RFP) postings.

Sign Up for Alerts
Title Sort ascending
Grant Type
Focus Area
Country
Application Due Date
RSV Infection and RSV Maternal Immunization in Area of Obstetrics and Gynecology
Release Date:
Review Process: Pfizer Internal
Translation: Japanese (link)
Education Vaccines Japan
Transthyretin Cardiac Amyloidosis Fellowship
Release Date:
Review Process: Expert Review Panel
Fellowship Rare Disease USA
Release Date:
Review Process: Pfizer Internal
Education Internal Medicine USA
Develop Young Physicians to Lead the Increase in Preventive Awareness by Vaccination
Release Date:
Review Process: Pfizer Internal
Translation: Japanese (link)
Education Vaccines Japan
Optimizing maternal immunization practice and vaccination access during pregnancy in Italy
Release Date:
Review Process: Expert Review Panel
Quality Improvement Vaccines Italy
Sickle Cell Disease (SCD) Fellowship
Release Date:
Review Process: Expert Review Panel
Fellowship Rare Disease USA
Quality Improvement Grants to Support Development of Cardiac Amyloid Centers
Release Date:
Review Process: Pfizer Internal
Quality Improvement Rare Disease USA
Increasing Awareness and Understanding of Amyloid Transthyretin Cardiomyopathy (ATTR-CM)
Release Date:
Review Process: Pfizer Internal
Education Rare Disease USA
Quality Improvement Grants to Improve Identification and Management of Patients with ATTR Amyloidosis
Release Date:
Review Process: Pfizer Internal
Quality Improvement Rare Disease Spain
2024 Raising Awareness and Promoting Timely Diagnosis of TTR Amyloidosis
Release Date:
Partner: Global Bridges at Mayo Clinic
Review Process: Expert Review Panel
Quality Improvement Rare Disease All
Closing the HRRm Testing Gap in Prostate Cancer Patients
Release Date:
Review Process: Expert Review Panel
Translation: French (link)
Quality Improvement Oncology Canada
Cancer Registry
Release Date:
Review Process: Pfizer Internal
Translation: French (link)
Research Oncology Congo, The Democratic Republic
Title Sort ascending
Grant Type
Focus Area
Country
Application Due Date
Improving the Care of Persons Living with Metastatic Breast Cancer
Release Date:
Partner: Rethink Breast Cancer
Review Process: Expert Review Panel
Translation: French (link)
Quality Improvement Oncology Canada
Improving Metastatic Breast Cancer (mBC) Quality of Care and Equity via Meaningful Capacity Building in South East Asia
Release Date:
Partner: Conquer Cancer®, the ASCO Foundation
Review Process: Expert Review Panel
Quality Improvement Oncology Hong Kong, Indonesia, Malaysia, Myanmar, Papua New Guinea, Philippines, Singapore, Solomon Islands, Taiwan, Thailand, Vietnam
Providing Appropriate Medical Care for IBD Patients
Release Date:
Partner: Japanese Society for Inflammatory Bowel Disease (JSIBD)
Review Process: Expert Review Panel
Quality Improvement Inflammation & Immunology Japan
Real World Evidence of Abrocitinib in Patients with Moderate-to-Severe Atopic Dermatitis
Release Date:
Review Process: Pfizer Internal
Research Inflammation & Immunology All
Addressing knowledge and practice gaps in changing paradigms of dermatological inflammatory conditions
Release Date:
Review Process: Pfizer Internal
Translation: French (link)
Education Inflammation & Immunology Canada
LMIC Pharmacovigilance Education
Release Date:
Review Process: Pfizer Internal
Education Patient Safety Kenya, Lesotho, Swaziland
Knowledge Gaps in Drug-Drug Interactions in COVID-19 Outpatient Treatment
Release Date:
Review Process: Pfizer Internal
Education Vaccines USA
Updates on RSV in Older Adults for Pharmacists
Release Date:
Review Process: Pfizer Internal
Education Vaccines USA
Burden of RSV Disease - Analyzing Local Surveillance Data for Older Adults (EM Geographic Scope)
Release Date:
Review Process: Pfizer Internal
Research Inflammation & Immunology All
Optimizing COVID-19 Treatment Strategies in Elderly Vulnerable Populations in Canada
Release Date:
Review Process: Pfizer Internal
Translation: French (link)
Quality Improvement Vaccines Canada
Optimizing Maternal Immunization Practice in Canada
Release Date:
Review Process: Pfizer Internal
Translation: French (link)
Quality Improvement Vaccines Canada
Promoting Understanding of Pneumonia Prevention
Release Date:
Review Process: Pfizer Internal
Education Vaccines Japan